Assessment Status | Rapid Review Complete |
HTA ID | - |
Drug | Infliximab |
Brand | Inflectra® |
Indication | For the treatment of Rheumatoid Arthritis, Adult Crohn’s disease, Paediatric Crohn’s disease, Ulcerative Colitis, Ankylosing Spondylitis, Psoriatic Arthritis and Psoriasis. |
Assessment Process | |
Rapid review commissioned | 10/09/2013 |
Rapid review completed | 20/09/2013 |
Rapid review outcome | Full Pharmacoeconomic Assessment Not Recommended |